Extracorporeal membrane oxygenation bridge to heart transplant: Trends following the allocation change
- PMID: 33090585
- DOI: 10.1111/jocs.15118
Extracorporeal membrane oxygenation bridge to heart transplant: Trends following the allocation change
Abstract
Background: This study compared outcomes of patients bridged with extracorporeal membrane oxygenation (ECMO) to orthotopic heart transplantation (OHT) following the recent heart allocation policy change.
Methods: The United Network of Organ Sharing Registry (UNOS) database was queried to examine OHT patients between 2010 and 2020 that were bridged with ECMO. Waitlist outcomes and 1-year posttransplant survival were compared between patients waitlisted and/or transplanted before and after the heart allocation policy change. Secondary outcomes included posttransplant stroke, renal failure, and 1-year rejection.
Results: A total of 285 waitlisted patients were included, 173 (60.7%) waitlisted under the old policy and 112 (39.3%) under the new policy. New policy patients were more likely to receive OHT (82.2% vs. 40.6%), and less likely to be removed from the waitlist due to death or clinical deterioration (15.0% vs. 41.3%; both p < .001). A total of 165 patients bridged from ECMO to OHT were analyzed, 72 (43.6%) transplanted during the old policy and 93 (56.3%) under the new. Median waitlist time was reduced under the new policy (4 days [interquartile range {IQR}: 2-6] vs. 47 days [IQR: 10-228]). Postoperative renal failure was higher in the new policy group (23% vs. 6%; p = .002), but rates of stroke and 1-year acute rejection were equivalent. One-year survival was lower the new policy but was not significant (79.8% vs. 90.3%; p = .3917).
Conclusions: The UNOS heart allocation policy change has resulted in decreased waitlist times and higher likelihood of transplant in patients supported with ECMO. Posttransplant 1-year survival has remained comparable although absolute rates are lower.
Keywords: ECMO; allocation; heart transplantation; outcomes; policy change.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Extracorporeal Life Support Organization Registry Report. https://www.elso.org/Registry/Statistics/InternationalSummary.aspx. Accessed June 25, 2020.
-
- Jasseron C, Lebreton G, Cantrelle C, et al. Impact of heart transplantation on survival in patients on venoarterial extracorporeal membrane oxygenation at listing in France. Transplantation. 2016;100(9):1979‐1987. https://doi.org/10.1097/TP.0000000000001265
-
- Fukuhara S, Takeda K, Kurlansky PA, Naka Y, Takayama H. Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults. J Thorac Cardiovasc Surg. 2018;155(4):1607‐1618.e6. https://doi.org/10.1016/j.jtcvs.2017.10.152
-
- OPTN Policies Effective as of June 18 2020. https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf. Accessed June 26, 2020.
-
- Poptsov V, Spirina E, Dogonasheva A, Zolotova E. Five years' experience with a peripheral veno‐arterial ECMO for mechanical bridge to heart transplantation. J Thorac Dis. 2019;11(Suppl 6):S889‐S901. https://doi.org/10.21037/jtd.2019.02.55
LinkOut - more resources
Full Text Sources